Skip to main content
. 2020 Sep 3;2020(9):CD009233. doi: 10.1002/14651858.CD009233.pub3

ACTRN12607000399493.

Study name A randomized controlled trial of a low vision self management program on quality of life in people with low vision.
Methods Study design: RCT
Number randomized: 240 (target)
Number analyzed: not reported
Number of centers: not reported
Date of first enrollment: January 2007
Length of follow‐up: 16 months
Sample size estimation: not reported
Participants Country: Australia
Age: not reported
Sex: not reported
Key inclusion criteria: aged 55 or older, visual impairment (visual acuity of <6/12 and >6/480 in the better eye with habitual correction), English‐speaking, no cognitive impairment, adequate hearing.
Key exclusion criteria: not reported
Comparability of baseline characteristics: not applicable
Interventions Behavioral intervention #1: participants receive new low vision self‐management program “Living with Low Vision”. It consist of eight 3‐hour weekly facilitated group sessions. The program is structured and a facilitator manual clearly outline the content and delivery. As well as providing information, the topics in the program are covered by exploring participants' experiences, difficulties and solutions. Participants are encouraged to draw on their extensive life experience and coping mechanisms and to develop new skills and strategies and apply these new techniques in their daily life. Participants are given the option to bring a relative, friend or acre to the program with them.
Control intervention #2: participants continue to access usual low vision rehabilitation services.
Outcomes Primary outcome: Vision Impairment Questionnaire (IVI) to assess the restriction of participation in daily activities in people with low vision, the Depression Anxiety Stress Scale (DASS) to assess psychological well‐being.
Secondary outcomes: (1) Adaptation to Age‐related Vision Loss Scale (AVL‐12), (2) The General Self‐Efficacy Scale (GSES), (3) The Health Education Impact Questionnaire (HEIQ) scale, (4) The Positive and Negative Affect Schedule (PANAS).
Starting date 1/03/2007
Contact information Professor Jill Keeffe
Notes The trial was recruiting participants, accessed on 01/31/2020, through:
http://apps.who.int/trialsearch/Trial3.aspx?trialid=ACTRN12607000399493.

IVI: Vision Impairment Questionnaire
DASS: Depression Anxiety Stress Scale
AVL‐12: Adaptation to Age‐related Vision Loss Scale
GSES: General Self‐Efficacy Scale
HEIQ: Health Education Impact Questionnaire
PANAS: Positive and Negative Affect Scale